Factor X deficiency is an important complication of amyloidosis. It is associated with severe bleeding that is difficult to control with plasma or prothrombin complex concentrates. Splenectomy ameliorates the factor X deficiency, but achieving satisfactory haemostasis for this operation is problematic. We report that a new clotting concentrate, recombinant factor VIIa, readily controls bleeding and makes splenectomy feasible.
|Original language||English (US)|
|Number of pages||2|
|Journal||British Journal of Haematology|
|State||Published - 2001|
- Factor X deficiency
- Recombinant factor VIIa
ASJC Scopus subject areas